Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower-neck involvement and post-concurrent chemoradiotherapy response predict distant metastasis in head and neck cancer.

Radiation oncology journal·2026
Same author

Polymeric Micelle Systems for Oral Drug Delivery of Small Molecule Therapeutics.

Pharmaceutics·2026
Same author

Generation of Functional Oligodendrocyte Progenitor Cells Through Serial Replating of iPSC-Derived NPC Spheres.

Cells·2026
Same author

Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD.

Digestive diseases and sciences·2026
Same author

Interpretable Two-Stage Machine Learning for Early and Full Drug Release Prediction in PLGA Microspheres.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma.

Drug design, development and therapy·2026

Related Experiment Video

Updated: May 5, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.0K

Advancing Small-Molecule Immunotherapy Through Polymeric Micelle Delivery.

Kiran Suwal1, Hyunji Lee2, Saroj Bashyal3

  • 1College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea.

Pharmaceutics
|May 4, 2026
PubMed
Summary
This summary is machine-generated.

Polymeric micelles improve small-molecule immunomodulators by enhancing solubility and controlling drug exposure, overcoming clinical limitations for better cancer immunotherapy. This delivery system advances efficacy and safety.

Keywords:
drug deliveryimmunomodulatorspolymeric micellesmall-molecule drug

More Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.3K

Related Experiment Videos

Last Updated: May 5, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.0K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.3K

Area of Science:

  • Drug Delivery Systems
  • Immunotherapy
  • Nanotechnology

Background:

  • Small-molecule immunomodulators are key in modern immunotherapy, targeting various immune pathways.
  • Clinical underperformance is often due to poor physicochemical properties and rapid clearance, not target invalidity.
  • Polymeric micelles offer a versatile platform to enhance solubility, pharmacokinetics, and targeted delivery.

Purpose of the Study:

  • To review small-molecule immunomodulators and their delivery challenges.
  • To discuss polymeric micelle design principles for improved immunomodulator delivery.
  • To highlight how micelle-based delivery can enhance the efficacy and safety of immunotherapies.

Main Methods:

  • Classification of immunomodulators by immunological targets.
  • Examination of delivery constraints affecting therapeutic performance.
  • Discussion of polymeric micelle design strategies for solubilization, stimuli-responsive release, and co-delivery.

Main Results:

  • Polymeric micelles can overcome limitations of small-molecule immunomodulators by improving solubility and pharmacokinetics.
  • Micelle design enables enhanced target accumulation, stimuli-responsive release, and synchronized co-delivery.
  • Improved exposure control via micelle delivery enhances the efficacy of both direct immunomodulators and cytotoxic agents inducing immunogenic cell death.

Conclusions:

  • Polymeric micelles represent a promising strategy to advance the efficacy and safety of small-molecule immunomodulators.
  • Integrating immunopharmacology with formulation science is crucial for translational development.
  • Further research into micelle-based delivery systems is warranted for optimized cancer immunotherapy.